WEST PHARMACEUTICAL SERVICES, INC. Retained Earnings
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Retained Earnings of $4.62 billion as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-23
- 2026-06-30: Retained Earnings (Accumulated Deficit) $4.62B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) $4.48B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) $4.37B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) $4.26B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | $4.62B 10-Q · filed 2026-07-23 |
| 2026-03-31 | $4.48B 10-Q · filed 2026-04-23 |
| 2025-12-31 | $4.37B 10-Q · filed 2026-07-23 |
| 2025-09-30 | $4.26B 10-Q · filed 2025-10-23 |
| 2025-06-30 | $4.14B 10-Q · filed 2025-07-24 |
| 2025-03-31 | $4.03B 10-Q · filed 2025-04-24 |
| 2024-12-31 | $3.96B 10-K · filed 2026-02-17 |
| 2024-09-30 | $3.86B 10-Q · filed 2024-10-24 |
| 2024-06-30 | $3.72B 10-Q · filed 2024-07-25 |
| 2024-03-31 | $3.62B 10-Q · filed 2024-04-25 |
| 2023-12-31 | $3.52B 10-K · filed 2025-02-18 |
| 2023-09-30 | $3.42B 10-Q · filed 2023-10-26 |
| 2023-06-30 | $3.25B 10-Q · filed 2023-07-27 |
| 2023-03-31 | $3.11B 10-Q · filed 2023-04-27 |
| 2022-12-31 | $2.99B 10-K · filed 2024-02-20 |
| 2022-09-30 | $2.91B 10-Q · filed 2022-10-27 |
| 2022-06-30 | $2.79B 10-Q · filed 2022-07-28 |
| 2022-03-31 | $2.62B 10-Q · filed 2022-04-28 |
| 2021-12-31 | $2.46B 10-K · filed 2023-02-21 |
| 2021-09-30 | $2.34B 10-Q · filed 2021-10-28 |
| 2021-06-30 | $2.16B 10-Q · filed 2021-07-30 |
| 2021-03-31 | $1.99B 10-Q · filed 2021-04-30 |
| 2020-12-31 | $1.85B 10-K · filed 2022-02-22 |
| 2020-09-30 | $1.77B 10-Q · filed 2020-10-23 |
| 2020-06-30 | $1.70B 10-Q · filed 2020-07-24 |
| 2020-03-31 | $1.61B 10-Q · filed 2020-04-24 |
| 2019-12-31 | $1.55B 10-K · filed 2021-02-23 |
| 2019-09-30 | $1.50B 10-Q · filed 2019-10-29 |
| 2019-06-30 | $1.45B 10-Q · filed 2019-07-29 |
| 2019-03-31 | $1.40B 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.35B 10-K · filed 2020-02-24 |
| 2018-09-30 | $1.31B 10-Q · filed 2018-10-30 |
| 2018-06-30 | $1.26B 10-Q · filed 2018-07-31 |
| 2018-03-31 | $1.22B 10-Q · filed 2018-05-08 |
| 2018-01-01 | $1.19B 10-K · filed 2019-02-28 |
| 2017-12-31 | $1.18B 10-K · filed 2019-02-28 |
| 2017-09-30 | $1.19B 10-Q · filed 2017-10-31 |
| 2017-06-30 | $1.15B 10-Q · filed 2017-08-01 |
| 2017-03-31 | $1.12B 10-Q · filed 2017-05-05 |
| 2016-12-31 | $1.07B 10-K · filed 2018-02-26 |
| 2016-09-30 | $1.04B 10-Q · filed 2016-10-31 |
| 2016-06-30 | $1.01B 10-Q · filed 2016-08-01 |
| 2016-03-31 | $978.00M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $964.60M 10-K · filed 2017-02-28 |
| 2015-09-30 | $939.90M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $947.00M 10-Q · filed 2015-08-03 |
| 2015-03-31 | $927.20M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $902.20M 10-K · filed 2016-02-26 |
| 2014-09-30 | $878.70M 10-Q · filed 2014-11-03 |
| 2014-06-30 | $855.50M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $825.00M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $805.00M 10-K · filed 2015-02-25 |
| 2013-09-30 | $788.60M 10-Q · filed 2013-11-04 |
| 2012-12-31 | $719.90M 10-K · filed 2014-02-27 |
| 2011-12-31 | $664.50M 10-K · filed 2013-02-27 |
| 2010-12-31 | $612.60M 10-K/A · filed 2012-03-01 |
| 2009-12-31 | $569.40M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |